Welcome to LookChem.com Sign In|Join Free

CAS

  • or

90888-62-3

Post Buying Request

90888-62-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

90888-62-3 Usage

Description

(1H-Indol-2-ylmethyl)methylamine is a chemical compound that features an indole ring with a methylamine substituent at the 2-position. It is a primary amine characterized by the chemical formula C10H12N2. (1H-INDOL-2-YLMETHYL)METHYLAMINE is widely recognized for its potential biological activities and is a key intermediate in the synthesis of a diverse array of indole-based drugs, agrochemicals, and fine chemicals. Its significance in medicinal chemistry is underscored by its capacity to modulate the activity of various biological targets, positioning it as a valuable asset in drug discovery and development processes.

Uses

Used in Pharmaceutical Industry:
(1H-Indol-2-ylmethyl)methylamine is utilized as a building block for the synthesis of pharmaceuticals due to its ability to contribute to the development of indole-based drugs. Its presence in these compounds can enhance their efficacy and pharmacological properties, making it an essential component in the creation of novel medications.
Used in Agrochemical Industry:
In the agrochemical sector, (1H-Indol-2-ylmethyl)methylamine serves as a key intermediate in the production of various agrochemicals. Its incorporation can lead to the development of more effective and targeted agrochemicals, contributing to improved agricultural practices and crop protection.
Used in Fine Chemicals Industry:
(1H-Indol-2-ylmethyl)methylamine is also used as an intermediate in the synthesis of fine chemicals. Its versatility allows for its use in a wide range of applications, from the creation of specialty chemicals to the development of complex organic compounds for research and commercial purposes.
Used in Medicinal Chemistry Research:
(1H-Indol-2-ylmethyl)methylamine is employed as a valuable tool in medicinal chemistry research. Its ability to modulate the activity of biological targets makes it instrumental in the discovery and development of new drugs, as well as in understanding the mechanisms of action of existing pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 90888-62-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,8,8 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 90888-62:
(7*9)+(6*0)+(5*8)+(4*8)+(3*8)+(2*6)+(1*2)=173
173 % 10 = 3
So 90888-62-3 is a valid CAS Registry Number.

90888-62-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (1H-Indol-2-ylmethyl)methylamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:90888-62-3 SDS

90888-62-3Downstream Products

90888-62-3Relevant articles and documents

Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity

Li, Baoli,Ni, Shuaishuai,Mao, Fei,Chen, Feifei,Liu, Yifu,Wei, Hanwen,Chen, Wenhua,Zhu, Jin,Lan, Lefu,Li, Jian

, p. 224 - 250 (2018/02/10)

CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections. More than 100 new compounds were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1. Analogues 23a and 23b demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02-10.5 nM), along with lower hERG inhibition (IC50 > 30 μM, ~10-fold decrease in comparison with 1). Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid. Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.

FAB I INHIBITORS

-

, (2008/06/13)

Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 90888-62-3